Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 3/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.41 |
| ▸ | MGLL | Q99685 | 2/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | CDC25A | P30304 | 6/20 | 0.40 |
| ▸ | CES1 | P23141 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.38 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20434458 | 0.85 | PTGS1 (0.41) | PTGS1PTGS2MGLLFAAHCDC25A | |
| SCHEMBL13609450 | 0.80 | PTGS1 (0.39) | PTGS1PTGS2MGLLFAAHNPSR1 | |
| SCHEMBL13609448 | 0.80 | PTGS1 (0.39) | PTGS1PTGS2MGLLFAAHNPSR1 | |
| SCHEMBL20434454 | 0.78 | PTGS1 (0.45) | PTGS1PTGS2MGLLFAAHCYP1A2 | |
| SCHEMBL20434466 | 0.78 | PTGS1 (0.45) | PTGS1PTGS2MGLLFAAHCYP1A2 | |
| SCHEMBL20434472 | 0.78 | PTGS1 (0.45) | PTGS1PTGS2MGLLFAAHCYP1A2 | |
| SCHEMBL14560547 | 0.76 | CDC25A (0.56) | CDC25ACES1ALDH1A1ALDH2ALDH3A1 | |
| SCHEMBL14560544 | 0.71 | ALDH1A1 (0.41) | NPSR1ALDH1A1ALDH2ALDH3A1 | |
| SCHEMBL16356272 | 0.71 | PTGS1 (0.53) | PTGS1PTGS2MGLLFAAHCYP3A4 | |
| SCHEMBL15929294 | 0.71 | PTGS1 (0.53) | PTGS1PTGS2MGLLFAAHCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180219160-A1 | BENZOBIS(THIADIAZOLE) DERIVATIVE, INK COMPRISING THE SAME, AND ORGANIC ELECTRONIC DEVICE USING THE SAME | UBE INDUSTRIES, LTD. (JP) | 2018-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180219160-A1 | BENZOBIS(THIADIAZOLE) DERIVATIVE, INK COMPRISING THE SAME, AND ORGANIC ELECTRONIC DEVICE USING THE SAME | IKZF3, HELZ, TEC | PTGS1 2391/4885PTGS2 2445/4885MGLL 4773/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.